-
1
-
-
77952771512
-
-
Alzheimer's Disease International Prince M, Jackson J, London
-
Alzheimer's Disease International (2009) World Alzheimer Report. Prince M, Jackson J, London.
-
(2009)
World Alzheimer Report
-
-
-
3
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
-
(2010)
Lancet Neurol
, vol.9
, pp. 119-128
-
-
Jack Jr., C.R.1
Knopman, D.S.2
Jagust, W.J.3
Shaw, L.M.4
Aisen, P.S.5
Weiner, M.W.6
Petersen, R.C.7
Trojanowski, J.Q.8
-
4
-
-
79952740168
-
Transforming cerebrospinal fluid Abeta42 measures into calculated Pittsburgh Compound B units of brain Abeta amyloid
-
Weigand SD, Vemuri P, Wiste HJ, Senjem ML, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Tro-janowski JQ, Knopman DS, Jack CR Jr (2011) Transforming cerebrospinal fluid Abeta42 measures into calculated Pittsburgh Compound B units of brain Abeta amyloid. Alzheimers Dement 7, 133-141.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 133-141
-
-
Weigand, S.D.1
Vemuri, P.2
Wiste, H.J.3
Senjem, M.L.4
Pankratz, V.S.5
Aisen, P.S.6
Weiner, M.W.7
Petersen, R.C.8
Shaw, L.M.9
Tro-Janowski, J.Q.10
Knopman, D.S.11
Jack Jr., C.R.12
-
5
-
-
84865529158
-
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
-
Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367, 795-804.
-
(2012)
N Engl J Med
, vol.367
, pp. 795-804
-
-
Bateman, R.J.1
Xiong, C.2
Benzinger, T.L.3
Fagan, A.M.4
Goate, A.5
Fox, N.C.6
Marcus, D.S.7
Cairns, N.J.8
Xie, X.9
Blazey, T.M.10
Holtzman, D.M.11
Santacruz, A.12
Buckles, V.13
Oliver, A.14
Moulder, K.15
Aisen, P.S.16
Ghetti, B.17
Klunk, W.E.18
McDade, E.19
Martins, R.N.20
Masters, C.L.21
Mayeux, R.22
Ringman, J.M.23
Rossor, M.N.24
Schofield, P.R.25
Sperling, R.A.26
Salloway, S.27
Morris, J.C.28
more..
-
6
-
-
84863198003
-
Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: A voxelwise PiB-PET longitudinal study
-
Villain N, Chetelat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL (2012) Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: A voxelwise PiB-PET longitudinal study. Brain 135, 2126-2139.
-
(2012)
Brain
, vol.135
, pp. 2126-2139
-
-
Villain, N.1
Chetelat, G.2
Grassiot, B.3
Bourgeat, P.4
Jones, G.5
Ellis, K.A.6
Ames, D.7
Martins, R.N.8
Eustache, F.9
Salvado, O.10
Masters, C.L.11
Rowe, C.C.12
Villemagne, V.L.13
-
7
-
-
84873361594
-
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers
-
Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Cal-houn VD, Coleman RE, Doraiswamy PM (2013) Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266, 583-591.
-
(2013)
Radiology
, vol.266
, pp. 583-591
-
-
Shaffer, J.L.1
Petrella, J.R.2
Sheldon, F.C.3
Choudhury, K.R.4
Cal-Houn, V.D.5
Coleman, R.E.6
Doraiswamy, P.M.7
-
8
-
-
84868642306
-
Tracking the insidious course of Alzheimer's disease
-
Corner NC (2012) Tracking the insidious course of Alzheimer's disease. Nat Med 18, 1342-1343.
-
(2012)
Nat Med
, vol.18
, pp. 1342-1343
-
-
Corner, N.C.1
-
9
-
-
66549106850
-
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease
-
Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132, 1355-1365.
-
(2009)
Brain
, vol.132
, pp. 1355-1365
-
-
Jack Jr., C.R.1
Lowe, V.J.2
Weigand, S.D.3
Wiste, H.J.4
Senjem, M.L.5
Knopman, D.S.6
Shiung, M.M.7
Gunter, J.L.8
Boeve, B.F.9
Kemp, B.J.10
Weiner, M.11
Petersen, R.C.12
-
11
-
-
78049486915
-
Relationship of dementia screening tests with biomarkers of Alzheimer's disease
-
Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC (2010) Relationship of dementia screening tests with biomarkers of Alzheimer's disease. Brain 133, 3290-3300.
-
(2010)
Brain
, vol.133
, pp. 3290-3300
-
-
Galvin, J.E.1
Fagan, A.M.2
Holtzman, D.M.3
Mintun, M.A.4
Morris, J.C.5
-
12
-
-
35948933394
-
Classification and prediction of clinical Alzheimer's diagnosis basedonplasma signaling proteins
-
Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Kary-das A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T (2007) Classification and prediction of clinical Alzheimer's diagnosis basedonplasma signaling proteins. Nat Med 13, 1359-1362.
-
(2007)
Nat Med
, vol.13
, pp. 1359-1362
-
-
Ray, S.1
Britschgi, M.2
Herbert, C.3
Takeda-Uchimura, Y.4
Boxer, A.5
Blennow, K.6
Friedman, L.F.7
Galasko, D.R.8
Jutel, M.9
Kary-Das, A.10
Kaye, J.A.11
Leszek, J.12
Miller, B.L.13
Minthon, L.14
Quinn, J.F.15
Rabinovici, G.D.16
Robinson, W.H.17
Sabbagh, M.N.18
So, Y.T.19
Sparks, D.L.20
Tabaton, M.21
Tinklenberg, J.22
Yesavage, J.A.23
Tibshirani, R.24
Wyss-Coray, T.25
more..
-
13
-
-
82855163989
-
A blood-based screening tool for Alzheimer's disease that spans serum andplasma:Findingsfrom TARC and ADNI
-
O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R (2011) A blood-based screening tool for Alzheimer's disease that spans serum andplasma:Findingsfrom TARC and ADNI. PLoS One 6, e28092.
-
(2011)
PLoS One
, vol.6
-
-
O'Bryant, S.E.1
Xiao, G.2
Barber, R.3
Huebinger, R.4
Wilhelmsen, K.5
Edwards, M.6
Graff-Radford, N.7
Doody, R.8
Diaz-Arrastia, R.9
-
14
-
-
84867339786
-
Alzheimer's Disease Neuroimaging I, Australian Imaging B, Lifestyle Research G (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease
-
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN, Alzheimer's Disease Neuroimaging I, Australian Imaging B, Lifestyle Research G (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69, 1318-1325.
-
Arch Neurol
, vol.69
, pp. 1318-1325
-
-
Doecke, J.D.1
Laws, S.M.2
Faux, N.G.3
Wilson, W.4
Burnham, S.C.5
Lam, C.P.6
Mondal, A.7
Bedo, J.8
Bush, A.I.9
Brown, B.10
De Ruyck, K.11
Ellis, K.A.12
Fowler, C.13
Gupta, V.B.14
Head, R.15
MacAulay, S.L.16
Pertile, K.17
Rowe, C.C.18
Rembach, A.19
Rodrigues, M.20
Rumble, R.21
Szoeke, C.22
Taddei, K.23
Taddei, T.24
Trounson, B.25
Ames, D.26
Masters, C.L.27
Martins, R.N.28
more..
-
15
-
-
78751692575
-
Anti-abeta therapeutics in Alzheimer's disease: The need for a paradigm shift
-
Golde TE, Schneider LS, Koo EH (2011) Anti-abeta therapeutics in Alzheimer's disease: The need for a paradigm shift. Neuron 69, 203-213.
-
(2011)
Neuron
, vol.69
, pp. 203-213
-
-
Golde, T.E.1
Schneider, L.S.2
Koo, E.H.3
-
16
-
-
84862956941
-
Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment
-
Zhang S, Han D, Tan X, Feng J, Guo Y, Ding Y (2012) Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment. Int J Clin Pract 66, 185-198.
-
(2012)
Int J Clin Pract
, vol.66
, pp. 185-198
-
-
Zhang, S.1
Han, D.2
Tan, X.3
Feng, J.4
Guo, Y.5
Ding, Y.6
-
18
-
-
84897108729
-
A blood-based predictor for neocortical Abeta burden in Alzheimer's disease: Results from the AIBL study
-
doi: 10.1038/mp.2013.40 [Epub ahead of print
-
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL, Alzheimer's Disease Neu-roimaging I, Australian Imaging B, Lifestyle Study Research G (2013) A blood-based predictor for neocortical Abeta burden in Alzheimer's disease: Results from the AIBL study. Mol Psychiatry, 2013. doi: 10.1038/mp.2013.40 [Epub ahead of print].
-
(2013)
Mol Psychiatry
-
-
Burnham, S.C.1
Faux, N.G.2
Wilson, W.3
Laws, S.M.4
Ames, D.5
Bedo, J.6
Bush, A.I.7
Doecke, J.D.8
Ellis, K.A.9
Head, R.10
Jones, G.11
Kiiveri, H.12
Martins, R.N.13
Rembach, A.14
Rowe, C.C.15
Salvado, O.16
MacAulay, S.L.17
Masters, C.L.18
Villemagne, V.L.19
-
19
-
-
18744394346
-
The 9 year cognitive decline before dementia of the Alzheimer type: A prospective population-based study
-
Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, Barberger-Gateau P, Fabrigoule C, Dartigues JF (2005) The 9 year cognitive decline before dementia of the Alzheimer type: A prospective population-based study. Brain 128, 1093-1101.
-
(2005)
Brain
, vol.128
, pp. 1093-1101
-
-
Amieva, H.1
Jacqmin-Gadda, H.2
Orgogozo, J.M.3
Le Carret, N.4
Helmer, C.5
Letenneur, L.6
Barberger-Gateau, P.7
Fabrigoule, C.8
Dartigues, J.F.9
-
20
-
-
84874331567
-
Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis
-
Schmid NS, Taylor KI, Foldi NS, Berres M, Monsch AU (2013) Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis. J Alzheimers Dis 34, 537-546.
-
(2013)
J Alzheimers Dis
, vol.34
, pp. 537-546
-
-
Schmid, N.S.1
Taylor, K.I.2
Foldi, N.S.3
Berres, M.4
Monsch, A.U.5
-
21
-
-
11144302567
-
Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset
-
Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC, Newman AB, Kuller L (2004) Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 63, 2341-2347.
-
(2004)
Neurology
, vol.63
, pp. 2341-2347
-
-
Saxton, J.1
Lopez, O.L.2
Ratcliff, G.3
Dulberg, C.4
Fried, L.P.5
Carlson, M.C.6
Newman, A.B.7
Kuller, L.8
-
22
-
-
33745065899
-
Cognitive measures pre-dict pathologic Alzheimer disease
-
Powell MR, Smith GE, Knopman DS, Parisi JE, Boeve BF, Petersen RC, Ivnik RJ (2006) Cognitive measures pre-dict pathologic Alzheimer disease. Arch Neurol 63, 865-868.
-
(2006)
Arch Neurol
, vol.63
, pp. 865-868
-
-
Powell, M.R.1
Smith, G.E.2
Knopman, D.S.3
Parisi, J.E.4
Boeve, B.F.5
Petersen, R.C.6
Ivnik, R.J.7
-
23
-
-
69549097641
-
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
-
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D (2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21, 672-687.
-
(2009)
Int Psychogeriatr
, vol.21
, pp. 672-687
-
-
Ellis, K.A.1
Bush, A.I.2
Darby, D.3
De Fazio, D.4
Foster, J.5
Hudson, P.6
Lautenschlager, N.T.7
Lenzo, N.8
Martins, R.N.9
Maruff, P.10
Masters, C.11
Milner, A.12
Pike, K.13
Rowe, C.14
Savage, G.15
Szoeke, C.16
Taddei, K.17
Villemagne, V.18
Woodward, M.19
Ames, D.20
more..
-
24
-
-
79551495391
-
Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease
-
Villemagne VL, Pike KE, Chetelat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC (2011) Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol 69, 181-192.
-
(2011)
Ann Neurol
, vol.69
, pp. 181-192
-
-
Villemagne, V.L.1
Pike, K.E.2
Chetelat, G.3
Ellis, K.A.4
Mulligan, R.S.5
Bourgeat, P.6
Ackermann, U.7
Jones, G.8
Szoeke, C.9
Salvado, O.10
Martins, R.11
O'Keefe, G.12
Mathis, C.A.13
Klunk, W.E.14
Ames, D.15
Masters, C.L.16
Rowe, C.C.17
-
25
-
-
84891163157
-
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
-
doi:10.1016/j.jalz.2012.12.006
-
Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, Vanderstichele H, Barnham KJ, Ellis KA, Szoeke C, Macaulay L, Rowe CC, Villemagne VL, Ames D, Martins RN, Bush AI, Masters CL; AIBL research group (2012) Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimers Dement, doi:10.1016/j.jalz.2012.12.006
-
(2012)
Alzheimers Dement
-
-
Rembach, A.1
Faux, N.G.2
Watt, A.D.3
Pertile, K.K.4
Rumble, R.L.5
Trounson, B.O.6
Fowler, C.J.7
Roberts, B.R.8
Perez, K.A.9
Li, Q.X.10
Laws, S.M.11
Taddei, K.12
Rainey-Smith, S.13
Robertson, J.S.14
Vandijck, M.15
Vanderstichele, H.16
Barnham, K.J.17
Ellis, K.A.18
Szoeke, C.19
MacAulay, L.20
Rowe, C.C.21
Villemagne, V.L.22
Ames, D.23
Martins, R.N.24
Bush, A.I.25
Masters, C.L.26
more..
-
26
-
-
0026646604
-
Amyloid beta-peptide is produced by cultured cells during normal metabolism
-
Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mel-lon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
-
(1992)
Nature
, vol.359
, pp. 322-325
-
-
Haass, C.1
Schlossmacher, M.G.2
Hung, A.Y.3
Vigo-Pelfrey, C.4
Mel-Lon, A.5
Ostaszewski, B.L.6
Lieberburg, I.7
Koo, E.H.8
Schenk, D.9
Teplow, D.B.10
-
27
-
-
0029100939
-
Platelets are the primary source of amyloid beta-peptide in human blood
-
Chen M, Inestrosa NC, Ross GS, Fernandez HL (1995) Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 213, 96-103.
-
(1995)
Biochem Biophys Res Commun
, vol.213
, pp. 96-103
-
-
Chen, M.1
Inestrosa, N.C.2
Ross, G.S.3
Fernandez, H.L.4
-
28
-
-
0035907123
-
Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
-
Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP (2001) Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304, 102-106.
-
(2001)
Neurosci Lett
, vol.304
, pp. 102-106
-
-
Mehta, P.D.1
Pirttila, T.2
Patrick, B.A.3
Barshatzky, M.4
Mehta, S.P.5
-
29
-
-
74049111316
-
Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging
-
Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE (2010) Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 69, 98-108.
-
(2010)
J Neuropathol Exp Neurol
, vol.69
, pp. 98-108
-
-
Silverberg, G.D.1
Miller, M.C.2
Messier, A.A.3
Majmudar, S.4
MacHan, J.T.5
Donahue, J.E.6
Stopa, E.G.7
Johanson, C.E.8
-
30
-
-
77957963537
-
Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging
-
Silverberg GD, Messier AA, Miller MC, Machan JT, Maj-mudar SS, Stopa EG, Donahue JE, Johanson CE (2010) Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol 69, 1034-1043.
-
(2010)
J Neuropathol Exp Neurol
, vol.69
, pp. 1034-1043
-
-
Silverberg, G.D.1
Messier, A.A.2
Miller, M.C.3
MacHan, J.T.4
Maj-Mudar, S.S.5
Stopa, E.G.6
Donahue, J.E.7
Johanson, C.E.8
-
31
-
-
84861504318
-
Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent
-
Pascale CL, Miller MC, Chiu C, Boylan M, Caralopoulos IN, Gonzalez L, Johanson CE, Silverberg GD (2011) Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS 8, 21.
-
(2011)
Fluids Barriers CNS
, vol.8
, pp. 21
-
-
Pascale, C.L.1
Miller, M.C.2
Chiu, C.3
Boylan, M.4
Caralopoulos, I.N.5
Gonzalez, L.6
Johanson, C.E.7
Silverberg, G.D.8
-
32
-
-
33947223454
-
Cerebrospinal fluid tau/beta-amyloid(42) ratioas aprediction of cognitive declinein nondemented older adults
-
Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtz-man DM (2007) Cerebrospinal fluid tau/beta-amyloid(42) ratioas aprediction of cognitive declinein nondemented older adults. Arch Neurol 64, 343-349.
-
(2007)
Arch Neurol
, vol.64
, pp. 343-349
-
-
Fagan, A.M.1
Roe, C.M.2
Xiong, C.3
Mintun, M.A.4
Morris, J.C.5
Holtz-Man, D.M.6
-
33
-
-
78349287910
-
The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia
-
Spies PE, Slats D, Sjogren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM (2010) The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr Alzheimer Res 7, 470-476.
-
(2010)
Curr Alzheimer Res
, vol.7
, pp. 470-476
-
-
Spies, P.E.1
Slats, D.2
Sjogren, J.M.3
Kremer, B.P.4
Verhey, F.R.5
Rikkert, M.G.6
Verbeek, M.M.7
-
34
-
-
84873681445
-
A selected reaction monitoring (SRM)-based method for absolute quantification of Abeta38, Abeta40, and Abeta42 in cerebrospinal fluid of Alzheimer's Disease patients and healthy controls
-
Pannee J, Portelius E, Oppermann M, Atkins A, Hornshaw M, Zegers I, Hojrup P, Minthon L, Hansson O, Zetterberg H, Blennow K, Gobom J (2013) A selected reaction monitoring (SRM)-based method for absolute quantification of Abeta38, Abeta40, and Abeta42 in cerebrospinal fluid of Alzheimer's Disease patients and healthy controls. J Alzheimers Dis 33, 1021-1032.
-
(2013)
J Alzheimers Dis
, vol.33
, pp. 1021-1032
-
-
Pannee, J.1
Portelius, E.2
Oppermann, M.3
Atkins, A.4
Hornshaw, M.5
Zegers, I.6
Hojrup, P.7
Minthon, L.8
Hansson, O.9
Zetterberg, H.10
Blennow, K.11
Gobom, J.12
-
35
-
-
80052802801
-
Meta-analysis of plasma amyloid-beta levels in Alzheimer's disease
-
Song F, Poljak A, Valenzuela M, Mayeux R, Smythe GA, Sachdev PS (2011) Meta-analysis of plasma amyloid-beta levels in Alzheimer's disease. J Alzheimers Dis 26, 365-375.
-
(2011)
J Alzheimers Dis
, vol.26
, pp. 365-375
-
-
Song, F.1
Poljak, A.2
Valenzuela, M.3
Mayeux, R.4
Smythe, G.A.5
Sachdev, P.S.6
-
36
-
-
84863800460
-
Plasma amyloid-betaas apredictor ofdementia and cognitive decline:Asystematic review and meta-analysis
-
Koyama A, Okereke OI, Yang T, Blacker D, Selkoe DJ, Grod-stein F (2012) Plasma amyloid-betaas apredictor ofdementia and cognitive decline:Asystematic review and meta-analysis. Arch Neurol 69, 824-831.
-
(2012)
Arch Neurol
, vol.69
, pp. 824-831
-
-
Koyama, A.1
Okereke, O.I.2
Yang, T.3
Blacker, D.4
Selkoe, D.J.5
Grod-Stein, F.6
-
37
-
-
80054705807
-
Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI
-
Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR Jr, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM (2011) Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol 122, 401-413.
-
(2011)
Acta Neuropathol
, vol.122
, pp. 401-413
-
-
Toledo, J.B.1
Vanderstichele, H.2
Figurski, M.3
Aisen, P.S.4
Petersen, R.C.5
Weiner, M.W.6
Jack Jr., C.R.7
Jagust, W.8
Decarli, C.9
Toga, A.W.10
Toledo, E.11
Xie, S.X.12
Lee, V.M.13
Trojanowski, J.Q.14
Shaw, L.M.15
-
38
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
Bennett, D.A.4
Craft, S.5
Fagan, A.M.6
Iwatsubo, T.7
Jack Jr., C.R.8
Kaye, J.9
Montine, T.J.10
Park, D.C.11
Reiman, E.M.12
Rowe, C.C.13
Siemers, E.14
Stern, Y.15
Yaffe, K.16
Carrillo, M.C.17
Thies, B.18
Morrison-Bogorad, M.19
Wagster, M.V.20
Phelps, C.H.21
more..
|